Literature DB >> 11170720

Cortical and striatal neuronal cultures of the same embryonic origin show intrinsic differences in glutamate receptor expression and vulnerability to excitotoxicity.

A D Kovács1, G Cebers, A Cebere, T Moreira, S Liljequist.   

Abstract

Cortical and striatal cultures were prepared from the same embryonic rat brains and maintained in identical culture conditions. In this way, the intrinsic, genetically imprinted differences determine the responses of cortical and striatal neurons in comparative studies. Cortical and striatal neurons differed in their sensitivity to glutamate receptor-mediated neurotoxicity as measured by the MTT cell viability assay. On the 8th day in vitro, striatal cultures were less sensitive to N-methyl-d-aspartate (NMDA)-induced toxicity than cortical, although both cultures were equally vulnerable to alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA)- or kainate-induced toxicity. The AMPA receptor-mediated cell death in cortical cultures, however, was much more dependent on preventing AMPA receptor desensitization than in striatal cultures. Furthermore, glutamate-induced neurotoxicity was primarily mediated by NMDA receptors in cortical cultures, while blockade of either NMDA or AMPA receptors gave almost complete protection against glutamate in striatal cultures. To elucidate the molecular mechanisms responsible for the observed differences, we analyzed the expression of NMDA receptor subunits (NR1, NR2A-C) at the mRNA and the protein level in cortical and striatal cultures as well as in standard cerebellar granule cell cultures. The lowest expression level of NMDA receptor subunits was found in striatal cultures, thereby providing a possible explanation for their lower sensitivity to NMDA. Remarkable differences were found between the relative rates of mRNA and protein expression for NR1 and NR2B in the three cultures, indicative of intrinsic differences in the posttranscriptional regulation of NMDA receptor subunit expression in cultures from various brain regions. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170720     DOI: 10.1006/exnr.2000.7576

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  7 in total

1.  Synergistic Toxicity of the Neurometabolites Quinolinic Acid and Homocysteine in Cortical Neurons and Astrocytes: Implications in Alzheimer's Disease.

Authors:  Paula Pierozan; Helena Biasibetti-Brendler; Felipe Schmitz; Fernanda Ferreira; Carlos Alexandre Netto; Angela T S Wyse
Journal:  Neurotox Res       Date:  2017-11-09       Impact factor: 3.911

2.  Altered sensitivity to excitotoxic cell death and glutamate receptor expression between two commonly studied mouse strains.

Authors:  Rozzy Finn; Attila D Kovács; David A Pearce
Journal:  J Neurosci Res       Date:  2010-09       Impact factor: 4.164

3.  Altered glutamate receptor function in the cerebellum of the Ppt1-/- mouse, a murine model of infantile neuronal ceroid lipofuscinosis.

Authors:  Rozzy Finn; Attila D Kovács; David A Pearce
Journal:  J Neurosci Res       Date:  2011-10-04       Impact factor: 4.164

4.  Decreased sensitivity of palmitoyl protein thioesterase 1-deficient neurons to chemical anoxia.

Authors:  Meredith Meyer; Attila D Kovács; David A Pearce
Journal:  Metab Brain Dis       Date:  2016-10-08       Impact factor: 3.584

5.  Ethanol differentially inhibits homoquinolinic acid- and NMDA-induced neurotoxicity in primary cultures of cerebellar granule cells.

Authors:  Aleta Cebere; Sture Liljequist
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

6.  Glutamate promotes proliferation of striatal neuronal progenitors by an NMDA receptor-mediated mechanism.

Authors:  Kelvin C Luk; Timothy E Kennedy; Abbas F Sadikot
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

7.  Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease.

Authors:  Jing Fan; Catherine M Cowan; Lily Y J Zhang; Michael R Hayden; Lynn A Raymond
Journal:  J Neurosci       Date:  2009-09-02       Impact factor: 6.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.